These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24068867)

  • 1. Unexpected effects of peripherally administered kynurenic acid on cortical spreading depression and related blood-brain barrier permeability.
    Oláh G; Herédi J; Menyhárt A; Czinege Z; Nagy D; Fuzik J; Kocsis K; Knapp L; Krucsó E; Gellért L; Kis Z; Farkas T; Fülöp F; Párdutz A; Tajti J; Vécsei L; Toldi J
    Drug Des Devel Ther; 2013; 7():981-7. PubMed ID: 24068867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitroglycerin enhances the propagation of cortical spreading depression: comparative studies with sumatriptan and novel kynurenic acid analogues.
    Knapp L; Szita B; Kocsis K; Vécsei L; Toldi J
    Drug Des Devel Ther; 2017; 11():27-34. PubMed ID: 28053504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kynurenic Acid and Its Synthetic Derivatives Protect Against Sepsis-Associated Neutrophil Activation and Brain Mitochondrial Dysfunction in Rats.
    Poles MZ; Nászai A; Gulácsi L; Czakó BL; Gál KG; Glenz RJ; Dookhun D; Rutai A; Tallósy SP; Szabó A; Lőrinczi B; Szatmári I; Fülöp F; Vécsei L; Boros M; Juhász L; Kaszaki J
    Front Immunol; 2021; 12():717157. PubMed ID: 34475875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin-1 potently induces Leão's cortical spreading depression in vivo in the rat: a model for an endothelial trigger of migrainous aura?
    Dreier JP; Kleeberg J; Petzold G; Priller J; Windmüller O; Orzechowski HD; Lindauer U; Heinemann U; Einhäupl KM; Dirnagl U
    Brain; 2002 Jan; 125(Pt 1):102-12. PubMed ID: 11834596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of systemic kynurenine on cortical spreading depression and its modulation by sex hormones in rat.
    Chauvel V; Vamos E; Pardutz A; Vecsei L; Schoenen J; Multon S
    Exp Neurol; 2012 Aug; 236(2):207-14. PubMed ID: 22587906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.
    Foster AC; Kemp JA; Leeson PD; Grimwood S; Donald AE; Marshall GR; Priestley T; Smith JD; Carling RW
    Mol Pharmacol; 1992 May; 41(5):914-22. PubMed ID: 1375317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical spreading depression augments kynurenate levels and reduces malonate toxicity in the rat cortex.
    Kiss C; Shepard PD; Bari F; Schwarcz R
    Brain Res; 2004 Mar; 1002(1-2):129-35. PubMed ID: 14988042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pan- and subtype-selective N-methyl-D-aspartate receptor antagonists on cortical spreading depression in the rat: therapeutic potential for migraine.
    Peeters M; Gunthorpe MJ; Strijbos PJ; Goldsmith P; Upton N; James MF
    J Pharmacol Exp Ther; 2007 May; 321(2):564-72. PubMed ID: 17267580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cortical spreading depression by L-701,324, a novel antagonist at the glycine site of the N-methyl-D-aspartate receptor complex.
    Obrenovitch TP; Zilkha E
    Br J Pharmacol; 1996 Mar; 117(5):931-7. PubMed ID: 8851513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of the kynurenic acid across the blood-brain barrier by core-shell nanoparticles.
    Varga N; Csapó E; Majláth Z; Ilisz I; Krizbai IA; Wilhelm I; Knapp L; Toldi J; Vécsei L; Dékány I
    Eur J Pharm Sci; 2016 Apr; 86():67-74. PubMed ID: 26924227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMDA-receptor blockers but not NBQX, an AMPA-receptor antagonist, inhibit spreading depression in the rat brain.
    Nellgård B; Wieloch T
    Acta Physiol Scand; 1992 Dec; 146(4):497-503. PubMed ID: 1283483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical role of calcitonin gene-related peptide receptors in cortical spreading depression.
    Tozzi A; de Iure A; Di Filippo M; Costa C; Caproni S; Pisani A; Bonsi P; Picconi B; Cupini LM; Materazzi S; Geppetti P; Sarchielli P; Calabresi P
    Proc Natl Acad Sci U S A; 2012 Nov; 109(46):18985-90. PubMed ID: 23112192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased extracellular K+ concentration reduces the efficacy of N-methyl-D-aspartate receptor antagonists to block spreading depression-like depolarizations and spreading ischemia.
    Petzold GC; Windmüller O; Haack S; Major S; Buchheim K; Megow D; Gabriel S; Lehmann TN; Drenckhahn C; Peters O; Meierkord H; Heinemann U; Dirnagl U; Dreier JP
    Stroke; 2005 Jun; 36(6):1270-7. PubMed ID: 15879337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of NMDA receptor subtypes in cortical spreading depression in rats assessed by fMRI.
    Shatillo A; Salo RA; Giniatullin R; Gröhn OH
    Neuropharmacology; 2015 Jun; 93():164-70. PubMed ID: 25688928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kynurenic acid and its derivatives are able to modulate the adhesion and locomotion of brain endothelial cells.
    Lajkó E; Tuka B; Fülöp F; Krizbai I; Toldi J; Magyar K; Vécsei L; Kőhidai L
    J Neural Transm (Vienna); 2018 Jun; 125(6):899-912. PubMed ID: 29332257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance to ketamine-induced blockade of cortical spreading depression transfers to MK-801 but not to AP5 in rats.
    Rashidy-Pour A; Motaghed-Larijani Z; Bures J
    Brain Res; 1995 Sep; 693(1-2):64-9. PubMed ID: 8653422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study on the effects of kynurenic acid and glucosamine-kynurenic acid.
    Füvesi J; Somlai C; Németh H; Varga H; Kis Z; Farkas T; Károly N; Dobszay M; Penke Z; Penke B; Vécsei L; Toldi J
    Pharmacol Biochem Behav; 2004 Jan; 77(1):95-102. PubMed ID: 14724046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid.
    Luchowska E; Luchowski P; Paczek R; Ziembowicz A; Kocki T; Turski WA; Wielosz M; Lazarewicz J; Urbanska EM
    J Neurosci Res; 2005 Feb; 79(3):375-82. PubMed ID: 15605380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic implications of cortical spreading depression models in migraine.
    Takizawa T; Ayata C; Chen SP
    Prog Brain Res; 2020; 255():29-67. PubMed ID: 33008510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spreading depression induces expression of calcium-independent protein kinase C subspecies in ischaemia-sensitive cortical layers: regulation by N-methyl-D-aspartate receptors and glucocorticoids.
    Koponen S; Keinänen R; Roivainen R; Hirvonen T; Närhi M; Chan PH; Koistinaho J
    Neuroscience; 1999; 93(3):985-93. PubMed ID: 10473263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.